Gralise
- Product NDC
- 50436-1262
- 11-digit product format
- 504361262
- Labeler code
- 50436
- Product ID
- 50436-1262_02926bb2-e906-467c-aae1-4dedaab2b7c3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- gabapentin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- NDA022544
- Marketing category
- NDA
- Marketing start
- 2011-01-28
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record